Sign in
Industry
Pharma
Biopharma
Vaccine
Biomed
Regulatory
Technology
Leader Spotlight
Academia
Science & Society
Research Spotlight
Scientist Spotlight
PhD & Postdoc
Awards
Campus Konnect
Fellowship & Grants
Conference & Training
Startup
Healthcare
Startup Konnect
Incubation Center
Startup Grants
Interviews
SciFocus TV
Sci Career Konnect
PhD Konnect
Storify India
Mentor Konnect
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Biopatrika
To bring science to society
Biopatrika
To bring science to society
Go
Search
Industry
Startup
Academia
Interviews
Category:
Industry
Academia
Awards
Biomed
Biopharma
Campus Konnect
Conference & Training
Science & Society
Global Trends in Antibiotic Consumption: 2016–2023 and Projections Through 2030
Press Release
Accord BioPharma Announces Agreement by Intas Pharmaceuticals, Ltd. to Acquire UDENYCA® (pegfilgrastim-cbqv) Business from Coherus BioSciences, Inc., Unlocking Potential for Continued U.S. Growth
Science & Society
A Blueprint for Broadly Effective Phage-Antibiotic Cocktails
Research Spotlight
Battling persistence in Tuberculosis: A tale of balanced regulation
Biopharma
CBT Course Series 2023 | IIT Delhi
Biopharma
NMR: A zooming lens for Biopharmaceutics
Biomed
Automated Pump: FDA Approves Next-Gen Insulin System
Research Spotlight
Artificial intelligence for pancreatic cancer diagnosis
Biomed
A novel approach to improve and increase the quality of stored blood
Research Spotlight
DNA: A next-generation material for digital Data Storage
Biomed
Exploring the role of efflux pumps and media composition in antibiotic responses of Pseudomonas aeruginosa
Biomed
A disposable sensor for diagnosing leptospirosis
Load more
Global Trends in Antibiotic Consumption: 2016–2023 and Projections Through 2030
December 5, 2024
Accord BioPharma Announces Agreement by Intas Pharmaceuticals, Ltd. to Acquire UDENYCA® (pegfilgrastim-cbqv) Business from Coherus BioSciences, Inc., Unlocking Potential for Continued U.S. Growth
December 4, 2024
A Blueprint for Broadly Effective Phage-Antibiotic Cocktails
December 3, 2024
U.S. FDA Approves Biocon Biologics’ YESINTEK™, Bmab 1200 biosimilar
December 1, 2024
Persistence of Spike Protein in Brain Borders May Drive COVID-19 Neurological Symptoms
December 1, 2024